Skip to main content

ISRG

Stock

ISRG

Stock
Health Care
Medical Instruments & Supplies

Performance overview

ISRG Price
Price Chart

Forward-looking statistics

Beta
0.64
Risk
28.19%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500.

Company info

SectorHealth Care
IndustryMedical Instruments & Supplies
Employees13K
Market cap$148.1B

Fundamentals

Enterprise value$190.4B
Revenue$8.7B
Revenue per employee—
Profit margin28.41%
Debt to equity0.00

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$6.81
Dividend per share—
Revenue per share$24.47
Avg trading volume (30 day)$837M
Avg trading volume (10 day)$831M
Put-call ratio—

Macro factor sensitivity

Growth-0.2
Credit+2.7
Liquidity+0.5
Inflation-3.6
Commodities+0.1
Interest Rates-1.8

Valuation

Dividend yield0.00%
PEG Ratio69.27
Price to sales22.39
P/E Ratio69.27
Enterprise Value to Revenue21.84
Price to book11.41

Upcoming events

Next earnings dayApril 23, 2025
Next dividend day—
Ex. dividend day—

News

Why Intuitive Surgical, Inc. (ISRG) Dipped More Than Broader Market Today

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $512.06, denoting a -2.66% move from the preceding trading day.

Zacks Investment Research (July 11, 2025)
Intuitive Surgical Stock: Why This Correction Is Healthy And What Lies Ahead

Intuitive Surgical ISRG is currently in Phase 17 of its 18-Phase Adhishthana Cycle. While the recent correction may be causing concern among investors, from the perspective of Adhishthana Principles, the pullback appears not only expected but also healthy.

Benzinga (June 11, 2025)
Cramer's Stop Trading: Intuitive Surgical

CNBC's Jim Cramer explains why he is keeping an eye on shares of Intuitive Surgical.

CNBC Television (June 9, 2025)
How pet medicine stocks could cushion your healthcare investments from Trump changes

Moderna shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investment Management portfolio manager Jason Kritzer shares his perspective on the pharmaceutical industry amid pushback from the Trump administration's Department of Health and Human Services (HHS) Secretary Robert F.

Yahoo Finance (June 2, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free